MGMT and glioblastoma: Covalent attachment of a chlorotoxin (CTX)‐targeted peptide‐modified NPCP enhanced delivery of benzylguanine to GBM; cells treated with NPCP‐BG‐CTX showed significantly reduced MGMT activity and enhanced TMZ toxicity.